Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancerMyrto Moutafi, Ioannis Vathiotis|Journal for ImmunoTherapy of Cancer|2021Cited by 51
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancerThazin Nwe Aung, David L. Rimm, James Monkman et al.|Nature Genetics|2025Cited by 33
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithmsThazin Nwe Aung, David L. Rimm, James S. Wilmott et al.|EBioMedicine|2022Cited by 33
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockadeIoannis Vathiotis, David L. Rimm|npj Precision Oncology|2022Cited by 8
Quantitative immunofluorescence and mRNA analysis of immune-related biomarker groups in matched paired tumor samples from OPHELIA window study in head and neck squamous cell carcinoma (HNSCC).Amanda Psyrri, David L. Rimm, Myrto Moutafi et al.|Journal of Clinical Oncology|2021Cited by 2